Rosemarie Martin

Dr. Rosemarie Martin


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2011 in Journal of Substance Abuse Treatment
Verified
Journal Article
Closed access
RMRosemarie Martin
Rosemarie Martin
SMSelene MacKinnon
Selene MacKinnon
JJJennifer Johnson
Jennifer Johnson
DRDamaris J. Rohsenow
Damaris J. Rohsenow

1 June 2006 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
RMRosemarie Martin
Rosemarie Martin
DRDamaris J. Rohsenow
Damaris J. Rohsenow
SMSelene Varney MacKinnon
Selene Varney MacKinnon
DADavid B. Abrams
David B. Abrams
PMPeter M. Monti
Peter M. Monti

1 October 2018 in American Journal of Public Health
Verified
Journal Article
Closed access
JCJennifer G. Clarke
Jennifer G. Clarke
RMRosemarie Martin
Rosemarie Martin
SGShelley A. Gresko
Shelley A. Gresko
JRJosiah D. Rich
Josiah D. Rich
American Journal of Public Health (AJPH) from the American Public Health Association (APHA) The First Comprehensive Program for Opioid Use Disorder in a US Statewide Correctional System, an article from American Journal of Public Health, Vol 108 Issue 10

23 December 2022 in The Lancet Regional Health - Americas
Verified
Journal Article
Open access
RMRosemarie Martin
Rosemarie Martin
NANicole Alexander-Scott
Nicole Alexander-Scott
JBJustin Berk
Justin Berk
RCRyan W. Carpenter
Ryan W. Carpenter
Augustine W. KangAugustine W. Kang
Augustine W. Kang
JCJennifer G. Clarke
Jennifer G. Clarke
As opioid overdoses surge, medications for opioid use disorder (MOUD) remain underutilized. MOUD is rarely offered in correctional facilities although individuals involved in the criminal justice system have higher rates of OUD and mortality relative to the general population. A retrospective cohort design examined the effect of MOUD while incarcerated on 12 months post-release treatment engagement and retention, overdose mortality, and recidivism. Individuals (N = 1600) who participated in the Rhode Island Department of Corrections (RIDOC) MOUD program (the United States' first statewide program) and were released from incarceration from December 1, 2016, to December 31, 2018, were included. The sample was 72.6% Male (27.4% female) and 80.8% White (5.8% Black, 11.4% Hispanic, 2.0% another race). 56% were prescribed methadone, 43% buprenorphine, and 1% naltrexone. During incarceration, 61% were continued on MOUD from the community, 30% were inducted onto MOUD upon incarceration, and 9% were inducted pre-release. At 30 days and 12 months post-release, 73% and 86% of participants engaged in MOUD treatment, respectively, and those newly inducted had lower post-release engagement than those who continued from the community. Reincarceration rates (52%) were similar to the general RIDOC population. Twelve overdose deaths occurred during the 12-month follow-up, with only one overdose death during the first two weeks post-release. Implementing MOUD in correctional facilities, with seamless linkage to community care is a needed life-saving strategy. Rhode Island General Fund, the NIH of Health HEAL Initiative, the NIGMS, and the NIDA.

5 October 2011 in BMC Public Health
Verified
Journal Article
Open access
PDF file
JCJennifer G Clarke
Jennifer G Clarke
RMRosemarie Martin
Rosemarie Martin
LSLar Stein
Lar Stein
CLCheryl E Lopes
Cheryl E Lopes
JMJennifer Mello
Jennifer Mello
BBBeth Bock
Beth Bock
Incarcerated individuals suffer disproportionately from the health effects of tobacco smoking due to the high smoking prevalence in this population. In addition there is an over-representation of ethnic and racial minorities, impoverished individuals, and those with mental health and drug addictions in prisons. Increasingly, prisons across the U.S. are becoming smoke free. However, relapse to smoking is common upon release from prison, approaching 90% within a few weeks. No evidence based treatments currently exist to assist individuals to remain abstinent after a period of prolonged, forced abstinence.

1 January 2000 in Journal of Consulting and Clinical Psychology
Verified
Journal Article
Closed access
DRDamaris Rohsenow
Damaris Rohsenow
PMPeter M. Monti
Peter M. Monti
RMRosemarie Martin
Rosemarie Martin
EMElizabeth Michalec
Elizabeth Michalec
DADavid B. Abrams
David B. Abrams
Patients (N = 108) in a study of cocaine-specific coping skills training (CST), which was found to reduce cocaine use during a 3-month follow-up, were followed for an additional 9 months. CST involved coping skills training in the context of high-risk situations. Control treatment used meditation-relaxation. Both were added to comprehensive private substance abuse treatment. Patients in CST who relapsed had significantly fewer cocaine use days than did the control group during the first 6 months, then both conditions did equally well. Patients in CST also drank alcohol more frequently in the last 6 months than did contrast patients but did not differ in heavy drinking days. For cocaine use outcomes, no interaction of treatment was found with gender, education, route of administration, drug use severity, sociopathy, or depression. Implications include the need to investigate different lengths and combinations of treatment.